Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a CD200 protein or a nucleic acid encoding a CD200 protein. The methods are useful in preventing graft rejection, fetal loss, autoimmune disease, and allergies. Methods and compositions for preventing immune suppression are also disclosed. The methods involve administering an effective amount of an agent that inhibits CD200. Such methods are useful in treating cancer.

 
Web www.patentalert.com

< Peptidic compounds selectively binding to P-selectin

> Mitotic kinesin inhibitors

> Substituted gamma lactams as therapeutic agents

~ 00530